Rocket Pharmaceuticals Inc. (9IP1)
Market Closed
3 Jun, 20:00
XFRA 
€
2. 4400
+0.05
+2.09%
€
- Market Cap
- P/E Ratio
- Div Yield
35 Volume
-3.06 Eps
€ 2.39
Previous Close Want to track 9IP1 and more in your Portfolio? 🎯
Sign up for Marketlog, a portfolio tracker that will exceed your expectations!
| Name | Time | Cons. EPS | Eps |
|---|---|---|---|
| | | - | - |
| | | - | - |
| | | - | - |
| | | - | - |
| | | - | - |
| | | - | - |
| | | - | - |
| | | - | - |
| | | - | - |
| | | - | - |
| | | - | - |
9IP1 Earnings Reports FAQ
What is the earnings per share (EPS) for 9IP1?
The current EPS is -3.06.
What is the company's earnings growth rate?
Rocket Pharmaceuticals Inc has not announced its next earnings release date. You can monitor upcoming announcements in Marketlog's earnings calendar or in the company profile.
When is the next earnings release date?
Rocket Pharmaceuticals Inc has not announced its next earnings release date.
What were the most recent quarterly earnings?
The most recent quarterly earnings for Rocket Pharmaceuticals Inc are not available at this time.
What is the price-to-earnings (P/E) ratio?
There is no P/E ratio for 9IP1 at this time, as Rocket Pharmaceuticals Inc has no recent EPS data to calculate it.
